Biolab Sanus Farmaceutica

2 in Phase 3

Quick facts

Phase 3 pipeline

Phase 1 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Biolab Sanus Farmaceutica

What is Biolab Sanus Farmaceutica's pipeline?

Biolab Sanus Farmaceutica has 2 drugs in Phase 3, 0 in Phase 2, 1 in Phase 1. Late-stage candidates include BL 3000, Reference Pantogar.

Related